PREVALENCE AND TREATMENT OF HYPERTENSIVES COMORBID WITH TYPE 2 DIABETES MELLITUS IN A NIGERIAN PRIVATE HOSPITAL
DOI:
https://doi.org/10.53555/nnpbs.v8i11.1418Keywords:
Comorbidity, Diabetes mellitus, Hypertension, PrevalenceAbstract
The coexistence of hypertension and diabetes accelerates the related complications and increases morbidities and mortalities.
The study investigated the prevalence and treatment of comorbid hypertension and diabetes in a private hospital.
References
Long AN, Dagogo?Jack S. Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. The journal of clinical hypertension, 2011; 13(4), 244-251.
Alloubani A, Saleh A, Abdelhafiz I. Hypertension and diabetes mellitus as a predictive risk factors for stroke. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2018; 12(4), 577-584.
Gutierrez J, Alloubani A, Mari M, Alzaatreh M. Cardiovascular disease risk factors: hypertension, diabetes mellitus and obesity among Tabuk citizens in Saudi Arabia. The open cardiovascular medicine journal, 2018; 12, 41.
Sunkara N, Ahsan CH. Hypertension in diabetes and the risk of cardiovascular disease. Cardiovascular endocrinology, 2017; 6(1), 33.
Yu HM, Liu GZ. Relationship between hypertension, diabetes mellitus, and cardiovascular disease. Mol Cardiol China, 2004; 4(1), 52-5
Eren NK, Harman E, Dolek D, Levent F. Rate of blood pressure control and antihypertensive treatment approaches in diabetic patients with hypertension. Arch Turk Soc Cardiol, 2014; 42(8), 733-740.
Wang, Z., Yang, T. & Fu, H. Prevalence of diabetes and hypertension and their interaction effects on cardio-cerebrovascular diseases: a cross-sectional study. BMC Public Health 2021; 21, 1224. https://doi.org/10.1186/s12889-021-11122-y.
Yu HM, Liu GZ. Relationship between hypertension, diabetes mellitus, and cardiovascular disease. Mol Cardiol China. 2004;4(1):52–5.
Wittchen HU, Krause P, Höfler M, et al. Diabetes mellitus und assoziierte Erkrankungen in der Allgemeinarztpraxis. Grössenordnung und Indikatoren der Belastung und der Versorgungsqualität [Hypertension, diabetes mellitus and comorbidity in primary care]. Fortschr Med Orig. 2003;121(Suppl 1):19–27.
Okosun IS, Chandra KM, Choi S, et al. Hypertension and type 2 diabetes comorbidity in adults in the United States: risk of overall and regional adiposity. Obes Res. 2001; 9(1):1–9.
Channanath AM, Farran B, Behbehani K, et al. State of diabetes, hypertension, and comorbidity in Kuwait: showcasing the trends as seen in native versus expatriate populations. Diab Care. 2013; 36(6): e75.
Hu G, Jousilahti P, Tuomilehto J. Joint effects of a history of hypertension at baseline and type 2 diabetes at baseline and during follow-up on the risk of coronary heart disease. Eur Heart J. 2007;28(24):3059–66.
Zafari N, Asgari S, Lotfaliany M, et al. Impact of Hypertension versus Diabetes on Cardiovascular and All-cause Mortality in Iranian Older Adults: Results of 14 Years of Follow-up. Sci Rep. 2017;7(1):14220.
Hu G, Sarti C, Jousilahti P’et al. The impact of a history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality. Stroke. 2005;36(12):2538–43.
Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high?risk patients. N Engl J Med. 2008; 359:2417.
Patel A, ADVANCE Collaborative Group, MacMahon S, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370:829.
Patel A & ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macro vascular and micro vascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. The Lancet, 2007, 370(9590), 829-840.
Diabetes Prevention Research Group . Impact of intensive lifestyle and metformin on cardiovascular risk factors in the diabetes prevention program (DPP). Diabetes Care. 2005;28(4):888–894.
Khaw KT, Wareham N, Bingham S, et al. Association of hemoglobin A1C with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med. 2004;141:413.
Ranney L, Melvin C, Lux L, et al. Systematic review: smoking cessation intervention strategies for adults and adults in special populations. Ann Intern Med. 2006;145:845–856.
Katzmarzyk PT, Church TS, Blair SN. Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men. Archives of internal medicine, 2004; 164(10), 1092-1097.
Ranney L, Melvin C, Lux L, McClain E, Lohr KN. Systematic review: smoking cessation intervention strategies for adults and adults in special populations. Annals of internal medicine, 2006; 145(11), 845-856.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Journal of Advance Research in Pharmacy & Biological Science
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
